India to Vietnam Pharmaceutical Export (2026) — $46.0M, 210 Suppliers | TransData Nexus

India to Vietnam Pharmaceutical Export (2026) — $46.0M, 210 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to Vietnam

#	Formulation	Value	Share
1	Dolutegravir+lamivudine+tenofovir Disoprtablet	$1.9M	4.2%
2	Abhayrab 0.5ml	$1.5M	3.2%
3	Peg-grafeel(qty:3500 Pfs)	$1.4M	3.1%
4	Redditux 500mg Vial(qty:2850 Vials)	$863.1K	1.9%
5	Proivig 5% - 100ml (human Normal Immunoglobulin 5%),pack: (100ml Vial)	$861.5K	1.9%
6	Myvelpa Sofosbuvir 400mg Velpatsvir 100mg 28bt Packs 4388	$730.1K	1.6%
7	Hertraz 440mg (trastuzumab for Injection (r Dna Origin) 440mg/vial),pack:(vial)	$645.9K	1.4%
8	Dolutegravir+lamivudine+tenofovir Disopr50mg+300mg+300mg Tablet	$424.2K	0.9%
9	Refix 550 (rifaximin 550mg)	$402.8K	0.9%
10	Velpatasvir Solid Dispersion 50% W/w(appendix 4r, Rodtep Entry No:10153)(our Re…	$384.5K	0.8%
11	Ampholip 50mg #	$377.5K	0.8%
12	Wosulin 30/70 Cartridge 100iu 3ml 1s	$340.8K	0.7%
13	Ciprofloxacin Tablets USP 500 MG 10x10 (49642 Pac)	$330.2K	0.7%
14	Pharmaceuticals Drugs & Medicines As Perinvoice No.bll/2526/013,dt:16.04.2025	$321.3K	0.7%
15	Redditux 100mg(qty:4300 Vials)	$302.3K	0.7%

India exports 20+ pharmaceutical formulations to Vietnam with a combined trade value of $46.0M. Key products include Dolutegravir ($1.9M), Sofosbuvir ($730K), Trastuzumab ($646K), Tenofovir ($424K), Velpatasvir ($384K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 3,365 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — India to Vietnam Trade Routes

1Dolutegravir$1.9M

2Sofosbuvir$730K

3Trastuzumab$646K

4Tenofovir$424K

5Velpatasvir$384K

Top Indian Exporters to Vietnam

1Hetero Labs Limited

$3.7M

2Dr.reddy's Laboratories Ltd

$3.2M

3Micro Labs Limited

$2.7M

4Rv Lifesciences Limited

$2.4M

5Brawn Laboratories Limited

Port Analysis — India to Vietnam Pharmaceutical Shipments

Indian Export Ports

NHAVA SHEVA SEA (INNSA1)14.2%

HYDERABAD ACC (INHYD4)1.9%

SAHAR AIR CARGO ACC (INBOM4)50.8%

DELHI AIR CARGO ACC (INDEL4)7.4%

BANGALORE ACC (INBLR4)2.4%

Vietnam Import Ports

HO CHI MINH C10.9%

HANOI - NOIBAI65.5%

Ho Chi Minh City10.1%

cat Lai4.7%

Haiphong3.9%

Trade Statistics

Total Value$46.0M

Shipments3,365

Indian Exporters210

Vietnam Buyers298

Avg Shipment$14K

Products1,801

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B France

Last updated: March 28, 2026

India–Vietnam Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade between India and Vietnam has experienced significant growth over the past decade. In 2024, India exported pharmaceutical products valued at $185.63 million to Vietnam, marking a substantial increase from previous years. This upward trajectory reflects the strengthening bilateral relations and the expanding demand for quality pharmaceutical products in Vietnam.

Key milestones in this trade evolution include the establishment of the ASEAN-India Free Trade Area (AIFTA) in 2010, which facilitated tariff reductions and improved market access for Indian pharmaceutical companies. Additionally, India's compliance with the World Health Organization's Good Manufacturing Practices (WHO-GMP) has bolstered its reputation as a reliable supplier of quality medicines, further enhancing trade volumes.

2India's Market Position

India holds a significant share in Vietnam's pharmaceutical import market, positioning itself as a key supplier alongside other countries. In 2023, Vietnam's pharmaceutical imports from India were valued at $274.99 million, indicating India's strong presence in the Vietnamese market. This market share underscores India's strategic importance in meeting Vietnam's growing healthcare needs.

3Recent Developments

Vietnam Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1Registration Process

Indian pharmaceutical companies seeking to register products in Vietnam must adhere to the Drug Administration of Vietnam's (DAV) requirements. The registration process involves submitting a comprehensive dossier that includes detailed information about the drug's composition, manufacturing process, and clinical data on safety and efficacy. (hmlf.vn) This ensures that imported medicines meet Vietnam's stringent quality standards.

The dossier should be prepared in accordance with the Common Technical Document (CTD) format, which is internationally recognized and facilitates the evaluation process. Additionally, products must comply with WHO-GMP standards, and manufacturers are subject to GMP assessments conducted by the Vietnamese authorities. The evaluation process is thorough, involving document review and on-site inspections to verify compliance with GMP standards.

2GMP & Facility Requirements

Vietnam requires that foreign pharmaceutical manufacturers, including Indian companies, comply with GMP standards recognized by the World Health Organization (WHO). Manufacturing facilities must undergo GMP assessments conducted by the Vietnamese Ministry of Health to ensure adherence to these standards. The assessment process includes a detailed evaluation of the facility's quality management systems, production processes, and documentation practices.

Mutual recognition agreements between Vietnam and other countries may facilitate the acceptance of GMP certifications from those countries. However, Indian manufacturers should verify the specific requirements and procedures with the DAV to ensure compliance. Maintaining up-to-date GMP certifications and adhering to Vietnam's regulatory standards are crucial for continued market access.

3Import Documentation

To import pharmaceutical products into Vietnam, Indian exporters must provide several key documents:

Import Order: An original copy of the import order using the prescribed forms.

Pharmaceutical Product Certificate: An original or notarized copy certifying the product's registration and approval in the country of origin.

Quality Standards and Testing Methods: Notarized copies detailing the product's quality standards and testing methods, sealed by the importing facility.

Labels and Usage Instructions: Original sets of labels and usage instructions in the language of the exporting country, along with proposed labels in Vietnamese.

Clinical Data: Clinical data on safety and efficacy, as per the drug registration regulations of the Vietnamese Ministry of Health.

GMP Certificate: An original or notarized copy of the GMP certificate for all participating manufacturing facilities.

These documents ensure that imported pharmaceutical products meet Vietnam's regulatory standards and are safe for public use. (medgate.vn)

EXPORT_TRENDS

TransData Nexus Research · Vietnam regulatory databasesMar 2026

Product Categories & Therapeutic Trends — India to Vietnam

Dominant categories, emerging opportunities, and demand drivers

1Dominant Categories

India's pharmaceutical exports to Vietnam are predominantly in the form of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. This aligns with Vietnam's healthcare needs, as the country seeks to provide accessible and affordable medicines to its population. The demand for these products is driven by the prevalence of chronic diseases, infectious diseases, and an aging population.

The top exported products include antiretroviral drugs like Dolutegravir, Lamivudine, and Tenofovir Disoproxil Fumarate tablets, vaccines such as Abhayrab 0.5ml, and immunoglobulins like Proivig 5% - 100ml. These products address critical health concerns in Vietnam, including HIV/AIDS, rabies, and immune deficiencies. The focus on these therapeutic areas underscores India's role in supporting Vietnam's public health objectives.

2Emerging Opportunities

The expiration of patents for several blockbuster drugs presents opportunities for Indian pharmaceutical companies to introduce generic versions in Vietnam. Additionally, the growing demand for biosimilars in Vietnam offers a promising avenue for Indian exporters, given India's established expertise in biosimilar development. Exploring new therapeutic areas, such as oncology and cardiology, can further diversify India's export portfolio to Vietnam.

3Demand Drivers

Vietnam's disease burden, characterized by high rates of infectious diseases like HIV/AIDS, tuberculosis, and hepatitis, drives the demand for pharmaceutical imports. The aging population further contributes to the need for chronic disease management, increasing the consumption of pharmaceutical products. Moreover, rising healthcare spending and government initiatives to improve healthcare infrastructure enhance the capacity to import and distribute medicines, creating a favorable environment for Indian pharmaceutical exports.

EXPORT_POLICY

TransData Nexus Research · DGFT trade data analysisMar 2026

FAQ — India to Vietnam Pharmaceutical Trade

What is the total value of India's pharmaceutical export to Vietnam?

India exported pharmaceuticals worth $46.0M to Vietnam across 3,365 verified shipments.

Who are the top Indian pharmaceutical exporters to Vietnam?

1. HETERO LABS LIMITED — $3.7M. 2. DR.REDDY'S LABORATORIES LTD — $3.2M. 3. MICRO LABS LIMITED — $2.7M. Total: 210 suppliers.

Which companies in Vietnam import pharmaceuticals from India?

1. TECHCOMBANK CHO LON BRANCH — $3.1M. 2. DUC MINH MEDICAL JOINT STOCK COMPAN — $2.6M. 3. HOANG DUC PHARMACEUTICAL & — $2.1M. 298 buyers total.

What pharmaceutical products does India export most to Vietnam?

1. Dolutegravir+lamivudine+tenofovir Disoprtablet ($1.9M, 4.2%); 2. Abhayrab 0.5ml ($1.5M, 3.2%); 3. Peg-grafeel(qty:3500 Pfs) ($1.4M, 3.1%); 4. Redditux 500mg Vial(qty:2850 Vials) ($863.1K, 1.9%); 5. Proivig 5% - 100ml (human Normal Immunoglobulin 5%),pack: (100ml Vial) ($861.5K, 1.9%)

Which ports handle pharmaceutical shipments from India to Vietnam?

Export: NHAVA SHEVA SEA (INNSA1), HYDERABAD ACC (INHYD4), SAHAR AIR CARGO ACC (INBOM4), DELHI AIR CARGO ACC (INDEL4), BANGALORE ACC (INBLR4). Import: HO CHI MINH C, HANOI - NOIBAI, Ho Chi Minh City, cat Lai, Haiphong.

Why does Vietnam import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $46.0M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Vietnam?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Vietnam pharmaceutical trade?

$13.7K per consignment across 3,365 shipments.

How many Indian pharmaceutical companies export to Vietnam?

210 Indian companies. Largest: HETERO LABS LIMITED with $3.7M.

How can I find verified Indian pharmaceutical suppliers for Vietnam?

TransData Nexus covers 210 active exporters with shipment history and trade values at transdatanexus.com.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Vietnam identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 3,365 verified shipments from 210 Indian exporters to 298 Vietnam buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

210 Exporters

298 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to Vietnam Pharmaceutical Export